Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,29 USD | -3,64% | -11,96% | -30,26% |
Omzet 2024 * | 7,3 mln. 5,3 mln. 4,98 mln. | Omzet 2025 * | 9,12 mln. 6,63 mln. 6,23 mln. | Marktkapitalisatie | 2,51 mln. 1,82 mln. 1,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,34 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,27 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 13 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,64% |
Recentste transcriptie over InMed Pharmaceuticals Inc.
1 dag | -3,64% | ||
1 week | -11,96% | ||
Lopende maand | -20,30% | ||
1 maand | -17,14% | ||
3 maanden | -19,08% | ||
6 maanden | -51,65% | ||
Lopend jaar | -30,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Chief Operating Officer | - | 05-11-18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11-02-22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Andrew Hull
CHM | Chairman | 61 | 12-09-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 0,29 | -3,64% | 58 949 |
18-04-24 | 0,301 | +0,33% | 131 018 |
17-04-24 | 0,3 | -1,78% | 260 209 |
16-04-24 | 0,3054 | -4,16% | 806 885 |
15-04-24 | 0,3187 | -3,28% | 103 193 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:30 uur
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,26% | 1,82 mln. | |
-3,10% | 102 mld. | |
+2,11% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,75% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,19% | 13,79 mld. | |
+0,18% | 13,33 mld. | |
+19,90% | 10,94 mld. |